Veradermics, Incorporated · NYSE:MANE
Viking Global Investors LP reported a 5.80% stake in Veradermics, Incorporated (Schedule 13G)
Event Feb 5, 2026 · Filed Feb 12, 2026
Viking Global Investors LP reported a 5.80% stake in Veradermics, Incorporated, 2,151,493 shares, as a passive investor on Feb 5, 2026. Filed Feb 12, 2026 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 2,151,493
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 11 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 5.80% | 2,151,493 |
| Viking Global Opportunities Parent GP LLC | 5.80% | 2,151,493 |
| Viking Global Opportunities GP LLC | 3.50% | 1,290,896 |
| Viking Global Opportunities Portfolio GP LLC | 3.50% | 1,290,896 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 3.50% | 1,290,896 |
| Viking Global Opportunities Drawdown GP LLC | 2.30% | 860,597 |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 2.30% | 860,597 |
| Viking Global Opportunities Drawdown (Aggregator) LP | 2.30% | 860,597 |
| HALVORSEN OLE ANDREAS | 5.80% | 2,151,493 |
| Ott David C. | 5.80% | 2,151,493 |
| Shabet Rose Sharon | 5.80% | 2,151,493 |
Source
Related
- Veradermics, Incorporated
- Viking Global Investors LP
- Veradermics, Incorporated shareholders
- Schedule 13G/A · Viking Global Investors LP · May 15, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Hollander David · Sep 3, 2026
- Form 4 · Averill Master Fund, Ltd. · Aug 21, 2026
- Schedule 13D/A · Montanova Capital, LLC · Aug 21, 2026
- Form 4 · Durso Timothy August · Aug 18, 2026